Predicting liver failure following major hepatectomy.
Pre-operative determination of the risk of liver dysfunction has come under criticism with regards to its usefulness in clinical practice. Opinion is split between centres which use such tests uniformly on all patients and those where clinical judgment alone is used. Published data would not suggest any difference in mortality, morbidity or liver failure rates between these groups. This review outlines and presents the evidence for pre-operative quantification of functional liver remnant volume.
Garcea
G
G
Department of Hepatobiliary and Upper Gastrointestinal Surgery, The Queen Elizabeth Hospital, Adelaide, SA 5011, Australia. gg43@le.ac.uk
Ong
S L
SL
Maddern
G J
GJ
D000418:Albumins; D015415:Biomarkers / Q000097:blood; D006498:Hepatectomy / Q000009:adverse effects*; D006801:Humans; D007208:Indocyanine Green; D017093:Liver Failure / Q000097:blood / Q000209:etiology*; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000601:surgery*; D015609:Organotechnetium Compounds; D011237:Predictive Value of Tests; D012307:Risk Factors; D012720:Severity of Illness Index; D015899:Tomography, Emission-Computed, Single-Photon
D000418:Albumins; D015415:Biomarkers; D015609:Organotechnetium Compounds; C036586:technetium Tc 99m neogalactoalbumin; D007208:Indocyanine Green